FEB 01, 2021 10:45 AM PST

As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing

WRITTEN BY: Carmen Leitch

Researchers have suggested that a simple genetic test could be a huge benefit to public health; it could tell clinicians whether a drug would be more effective if given to a patient in a different dose, or whether the patient needs to be monitored for side effects, for example. Pharmacogenetics is the study of how a person's genetics affects their response to drugs.

After analyzing data on prescriptions in the United Kingdom, researchers determined that four million UK patients could benefit every year if they were genetically tested before being prescribed common medications including antibiotics, antidepressants, painkillers, and stomach ulcer treatments. The study, published in the British Journal of Pharmacology, focused on 56 medications that have known drug-gene interactions and determined that in about one in five cases, international guidelines would recommend that a doctor or pharmacist change the prescription in some way.

That might involve prescribing the patient a lower or higher starting dose than normal, or being monitored carefully, whether by blood tests or with other means as the drug regimen was in the early stages. The study estimated that in about nine percent of cases, the dose would be altered or a completely different drug would be recommended - for the UK alone that would impact about five million prescriptions.

"We know over 95 percent of the population carry a genetic marker that predicts an atypical response to at least one medicine," explained Essra Youssef, a research pharmacist at the University of East Anglia's School of Pharmacy. "Our study looked at nine of these genetic markers, affecting 56 medicines that are commonly dispensed by community pharmacies in the UK. The most common of these are weak opioids, antidepressants, and proton-pump inhibitors, which are prescribed to reduce stomach acid."

Pharmacogenetic services that are in use in the Netherlands have indicated that clinicians that are trained to use these tests can apply the results to obtain better outcomes for patients.

Image credit: Pxhere

"We wanted to see how pharmacogenetic testing, before being prescribed common medicines, could benefit patients. We found that around four million patients annually in the UK could benefit from having this new technology," added Youssef. "Better selection of medicines based on a patient's genetic information could mean less side-effects and better treatment outcomes.

"It could also reduce hospital visits related to side effects of medicines. The testing process is quite simple in most cases, with a cheek swab sample collected and DNA analyzed for genes related to medicines."

"We strongly believe that pharmacy has a key role to play supporting the wider accessibility and use of pharmacogenomics," noted Marc Donovan, Chief Pharmacist at Boots UK.

Sources: AAAS/Eurekalert! via University of East Anglia, British Journal of Pharmacology

 

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 15, 2021
Genetics & Genomics
Green Tea Boosts a DNA-Repairing, Tumor-Suppressing Protein
FEB 15, 2021
Green Tea Boosts a DNA-Repairing, Tumor-Suppressing Protein
Green tea has been lauded for its medicinal qualities, though it's been difficult to show that definitively. A new study ...
FEB 21, 2021
Genetics & Genomics
How Spina Bifida Can Arise From Spontaneous Mutations
FEB 21, 2021
How Spina Bifida Can Arise From Spontaneous Mutations
Spina bifida is a birth defect that happens when the spinal cord of a developing infant doesn't form correctly, because ...
FEB 27, 2021
Cell & Molecular Biology
It's Now Possible to Measure tRNA Levels in Cells
FEB 27, 2021
It's Now Possible to Measure tRNA Levels in Cells
There are different kinds of ribonucleic acids that play essential roles in many aspects of molecular biology, including ...
MAR 06, 2021
Genetics & Genomics
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
MAR 06, 2021
Green Tea Extract Can Affect Facial Development in Kids With Down Syndrome
Individuals with Down syndrome often have certain facial features. New research has suggested that green tea supplements ...
MAR 23, 2021
Genetics & Genomics
Implementing Illumina NGS is a lot easier than you think.
MAR 23, 2021
Implementing Illumina NGS is a lot easier than you think.
Dr. John-Sebastian Eden is a Virologist at the Westmead Institute for Medical Research in Sydney, Australia. His group u ...
APR 14, 2021
Genetics & Genomics
The Smell of Home: Insights Into Scent Imprinting
APR 14, 2021
The Smell of Home: Insights Into Scent Imprinting
Right after birth, young animals go through a period in which they 'imprint,' or fixate on sights and smells that they'r ...
Loading Comments...